Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

How to Diagnose Antisynthetase Syndrome

How to Diagnose Antisynthetase Syndrome

Quretul Quresh, MD, & Stephen Lindsey, MD  |  March 17, 2017

Antisynthetase syndrome (AS) is strongly associated with the presence of antibodies to aminoacyl-transfer RNA (tRNA) synthetases (ARSs) that are implicated in the pathogenesis of myositis and interstitial lung disease (ILD). Antibodies against eight antisynthetases have been identified and are detected in 16–26% of patients with idiopathic inflammatory myopathies (IIM).1 Serum assays for five of these…

Filed under:ConditionsMyositisOther Rheumatic ConditionsResearch Rheum Tagged with:aminoacyl-transfer RNAAntisynthetase SyndromeClinicalDiagnosisinflammatoryInterstitial Lung DiseaseMyopathiesmyositisoutcomepatient careResearchrheumatologistrheumatologysyndromeTreatment

The ACR’s Representation in American Medical Association Critical as Review Looms

Sharad Lakhanpal, MBBS, MD  |  March 17, 2017

There is a saying that if the American Medical Association (AMA) did not exist, we would have to invent it. That is just what Dr. Nathan S. Davis did back in 1845 when he called for a national medical convention and laid the foundation for the establishment of the AMA in 1847. This new group would…

Filed under:President's Perspective Tagged with:AC&RAdvocacyAMAAmerican Board of Internal Medicine (ABIM)American College of Rheumatology (ACR)American Medical Association (AMA)benefitsmembershipreviewrheumatologist

What Our Colleagues Should Know: Neurologists & Rheumatologists Must Communicate

Richard Quinn  |  March 17, 2017

Neurologists and rheumatologists focus on atypical diseases, and their treatments often require insights from both specialties. Philip Seo, MD, MHS, says communication between specialists is key to diagnosis and treatment…

Filed under:Professional Topics Tagged with:central nervous systemNeurologyrheumatologist

AHCA, ACR Health Policy & More

Angus B. Worthing  |  March 16, 2017

Editor’s note: This blog by Dr. Worthing originally appeared on the ACR’s Advocacy Listserv. What a month! House Republicans introduced their bill to repeal and replace Obamacare. The ACR has analyzed the bill and believes the American Health Care Act (AHCA) does not go far enough to help Americans with rheumatic diseases. Brief recap: The…

Filed under:From the CollegeLegislation & Advocacy Tagged with:ACR Government Affairs CommitteeAmerican Health Care Act (AHCA)health policyimmigration orderObamacareTrump administration

Time to Rethink Inpatient Rehab After Knee Replacement?

Megan Brooks  |  March 14, 2017

NEW YORK (Reuters Health)—Inpatient rehabilitation did not lead to better mobility following total knee replacement compared with a home-based program in a randomized controlled trial (RCT) conducted in Australia. The findings do not support inpatient rehabilitation for adults undergoing uncomplicated total knee arthroplasty, conclude the authors in JAMA on March 14.1 “Normally, one study is…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:kneeknee arthroplastyrehabilitationtotal knee replacement

5 Skills for Successful Physician Management

Carina Stanton  |  March 10, 2017

After 39 years in rheumatology practice, Herbert Baraf, MD, says, “Management has a great influence over the quality of practice.” Here are some tips for physician management…

Filed under:Practice SupportWorkforce Tagged with:communicationManagementManagersPhysiciansPractice Management

Studies Highlight Gender, Racial Inequalities in Medical Profession

Andrew M. Seaman  |  March 7, 2017

(Reuters Health)—Women and minorities face more barriers to getting ahead in their medical careers, both early in training and later on, researchers say. In one study, Dr. Julie Boiko of the University of California, San Francisco, and colleagues found that women are underrepresented among speakers at grand rounds. This was true for all but two…

Filed under:Education & Training Tagged with:continuing medical educationGendergraduate medical educationmedical educationmedical schoolraceWomen

Infliximab Use Not Tied to Malignancy in Pediatric IBD

David Douglas  |  March 6, 2017

NEW YORK (Reuters Health)—Immunosuppressive therapy with infliximab (Remicade) for inflammatory bowel disease (IBD) in pediatric patients is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis (HLH), according to a Janssen study. Dr. Jeffrey S. Hyams, who worked on the study, calls the finding “reassuring.” He adds in an email to Reuters Health, “our…

Filed under:Biologics/DMARDsDrug Updates Tagged with:hemophagocytic lymphohistiocytosisHLHIBDinflammatory bowel diseaseinfliximab

What Rheumatologists Wish Their Colleagues Knew: Managing Skin Disease & Comorbidities

Richard Quinn  |  March 3, 2017

From treating rashes to uncovering a case of osteoarthritis, dermatologists and rheumatologists can work together in a variety of ways to improve patient care, says Joseph F. Merola, MD, MMSc…

Filed under:ConditionsPsoriatic ArthritisSystemic Sclerosis Tagged with:DermatologyPsoriasisPsoriatic Arthritisrheumatologistskinskin disease

ACR Puts Forward Principles on Patient Access to Care

Mary Beth Nierengarten  |  March 1, 2017

As the 115th Congress and the Trump administration consider potential reforms to the healthcare system, including actions related to the Affordable Care Act (ACA), physicians around the country remain vitally concerned about the need to preserve and improve access to care for their patients. To that end, the ACR continues to lobby for policies that…

Filed under:Legislation & AdvocacyPractice SupportProfessional Topics Tagged with:Access to carechronic arthritishealthcare coveragehealthcare provisionsongoing careposition statementrheumatic diseases

  • « Previous Page
  • 1
  • …
  • 203
  • 204
  • 205
  • 206
  • 207
  • …
  • 331
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences